Health Condition 1: K720- Acute and subacute hepatic failure Health Condition 2: E877- Fluid overload Health Condition 3: E889- Metabolic disorder, unspecified Health Condition 4: N178- Other acute kidney failure Health Condition 5: E878- Other disorders of electrolyte andfluid balance, not elsewhere classified Health Condition 6: E883- Tumor lysis syndrome
Conditions
Interventions
Intervention1: Continuous renal replacement therapy: In a critically ill child
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: Nil: Nil
Sponsors
Dr Yashkumar Prajapati
Eligibility
Inclusion criteria
Inclusion criteria: Pediatric patient who require continuous renal replacement therapy (CRRT) with regional citrate anticoagulation (RCA).
Exclusion criteria
Exclusion criteria: (1) Patients are already on systemic anticoagulation, such as heparin or warfarin. (2) Known inherited or acquired disorders of calcium or citrate metabolism, e.g. primary hypoparathyroidism, mitochondrial citrate transport defects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine proportion of patients showing survival of CRRT circuit.Timepoint: At 48 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine survival of CRRT circuit without citrate accumulation.Timepoint: At 72 hours;To measure incidence of severe bleeding, electrolyte imbalance, metabolic acidosis.Timepoint: Within 72 hours | — |
Countries
India
Contacts
Public ContactDr Arvind Bagga
INDRAPRASTHA APOLLO HOSPITAL
Outcome results
None listed